AURX Stock Price, Chart, Stats & News

Nuo Therapeutics, Inc.
Save
Nuo Therapeutics, Inc. (AURX) does not currently pay a dividend.
–
Market cap
–
Current P/E
–
Forward P/E
AURX chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Nuo Therapeutics, Inc. operates as a regenerative medicine company, specializing in the development, commercialization, and marketing of advanced cell-based technologies. These solutions are engineered to leverage the human body's inherent capacity for natural healing, with a primary focus on the United States market. Central to their offerings is a technology that isolates components from a patient's own blood (autologous) to generate a platelet-based therapy, specifically tailored for the treatment of chronic wounds.
Similar securities
Based on sector and market capitalization
Report issue





